3-Chloro-6-hydrazinopyridazine - CAS 17284-97-8
Catalog: |
BB012858 |
Product Name: |
3-Chloro-6-hydrazinopyridazine |
CAS: |
17284-97-8 |
Synonyms: |
(6-chloropyridazin-3-yl)hydrazine |
IUPAC Name: | (6-chloropyridazin-3-yl)hydrazine |
Description: | 3-Chloro-6-hydrazinopyridazine (CAS# 17284-97-8) is a useful research chemical. |
Molecular Weight: | 144.56 |
Molecular Formula: | C4H5ClN4 |
Canonical SMILES: | C1=CC(=NN=C1NN)Cl |
InChI: | InChI=1S/C4H5ClN4/c5-3-1-2-4(7-6)9-8-3/h1-2H,6H2,(H,7,9) |
InChI Key: | FXYQRYGWWZKUFV-UHFFFAOYSA-N |
Boiling Point: | 402.2 °C at 760 mmHg |
Purity: | 95+ % |
Density: | 1.53 g/cm3 |
MDL: | MFCD00051740 |
LogP: | 1.18890 |
GHS Hazard Statement: | H302 (91.3%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P272, P280, P301+P312, P302+P352, P305+P351+P338, P310, P321, P330, P333+P313, P363, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2021126779-A1 | Inhibitors of lin28 and methods of use thereof | 20191218 |
WO-2021023858-A1 | TrkB POSITIVE ALLOSTERIC MODULATORS | 20190808 |
US-2020377507-A1 | Ion channel modulators | 20190531 |
WO-2020230136-A1 | Acss2 inhibitors and methods of use thereof | 20190514 |
CN-109796456-A | New anticancer compound and application thereof | 20190124 |
PMID | Publication Date | Title | Journal |
21754036 | 20110401 | 3-Chloro-6-[2-(cyclo-pentyl-idene)hydrazin-1-yl]pyridazine | Acta crystallographica. Section E, Structure reports online |
20890645 | 20110101 | The synthesis, X-ray crystal structure and optical properties of novel 5-aryl-3-ferrocenyl-1-pyridazinyl-pyrazoline derivatives | Journal of fluorescence |
21587496 | 20100904 | 3-[(2E)-2-(Butan-2-yl-idene)hydrazin-yl]-6-chloro-pyridazine | Acta crystallographica. Section E, Structure reports online |
21588763 | 20100828 | 3-Chloro-6-[2-(propan-2-yl-idene)hydrazin-yl]pyridazine | Acta crystallographica. Section E, Structure reports online |
11712740 | 20010501 | Triazolo- and tetrazolopyridazine derivatives and their hypotension and heart rate activity | Acta poloniae pharmaceutica |
Complexity: | 88.6 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 144.0202739 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 144.0202739 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 63.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Pyrazines
Pyridazines
Customers Also Viewed
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[14245-62-6]
Isopropyl ethanesulfonate
-
[120739-62-0]
N-[(6-Chloropyridin-3-yl)methyl]-N-methylamine
-
[5518-18-3]
N-[2-(hexadecanoylamino)ethyl]hexadecanamide
-
[44994-28-7]
N,N,N',N'-Tetramethyl-1,5-pentanediamine
-
[1427004-19-0]
DBCO-PEG4-NHS ester
INDUSTRY LEADERS TRUST OUR PRODUCTS